Skip side navigation

Main contents starts here

Press Center

Topics

• February 3, 2010
  3rd Quarter of FY2009 financial results announcement & conference call

Latest Press Releases

• Show all

• March 5, 2010
  KAPIDEX^™ (dexlansoprazole) Renamed DEXILANT^™ in U.S. to Avoid Name Confusion
• March 3, 2010
  Lundbeck and Takeda finalise plans to initiate phase III pivotal clinical trials with Lu AA21004 and Lu AA24530

Press Releases' Search

---

Corporate Information

About Takeda	Investor Infomation
Overview Corporate Philosophy (Takeda-ism) Corporate Governance Management Plan Product Portfolio Reports & Publications	Financial Highlights Quarterly Results IR Calendar
Corporate Responsibility	Research & Development
CSR in Takeda	Core Therapeutic Areas Product Pipeline Drug Discovery

• Terms of Use
• Privacy Policy

Copyright © 1995-2010 Takeda Pharmaceutical Company Limited. All rights reserved.